Characterization of ductal carcinoma in situ cell lines established from breast tumor of a Singapore Chinese patient

[1]  M. Houshmand,et al.  Establishment and characterization of two human breast carcinoma cell lines by spontaneous immortalization: Discordance between Estrogen, Progesterone and HER2/neu receptors of breast carcinoma tissues with derived cell lines , 2012, Cancer Cell International.

[2]  John D. Minna,et al.  Molecular Profiling of Breast Cancer Cell Lines Defines Relevant Tumor Models and Provides a Resource for Cancer Gene Discovery , 2009, PloS one.

[3]  Takuya Moriya,et al.  Expression of basal keratins and vimentin in breast cancers of young women correlates with adverse pathologic parameters , 2008, Modern Pathology.

[4]  Ming Tan,et al.  Molecular mechanisms of erbB2-mediated breast cancer chemoresistance. , 2007, Advances in experimental medicine and biology.

[5]  Richard Lugg,et al.  Mutation analysis of 24 known cancer genes in the NCI-60 cell line set , 2006, Molecular Cancer Therapeutics.

[6]  M. Knowles,et al.  Expression of hTERT immortalises normal human urothelial cells without inactivation of the p16/Rb pathway , 2006, Oncogene.

[7]  D. Grignon,et al.  Loss of heterozygosity and microsatellite instability at the Xq28 and the A/G heterozygosity of the QM gene are associated with ovarian cancer , 2006, Cancer biology & therapy.

[8]  A. Vortmeyer,et al.  X‐chromosome loss of heterozygosity frequently occurs in gastrinomas and is correlated with aggressive tumor growth , 2004, Cancer.

[9]  T. Hubbard,et al.  A census of human cancer genes , 2004, Nature Reviews Cancer.

[10]  P. Rehak,et al.  Expression of MUC1 (EMA) and E-cadherin in renal cell carcinoma: a systematic immunohistochemical analysis of 188 cases , 2004, Modern Pathology.

[11]  A. Vincent-Salomon,et al.  Columnar Cell Lesions of the Breast , 2003, Advances in anatomic pathology.

[12]  Valerie Speirs,et al.  Breast cancer cell lines: friend or foe? , 2003, Breast Cancer Research.

[13]  S. Cocchi,et al.  Loss of heterozygosity at pseudoautosomal regions in human breast cancer and association with negative hormonal phenotype. , 2002, Cancer genetics and cytogenetics.

[14]  P. Drew,et al.  Intracellular Flow Cytometric Analysis of Primary Cultured Breast Tumor Cells , 2002, Cancer investigation.

[15]  J A Thomson,et al.  Short tandem repeat profiling provides an international reference standard for human cell lines , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[16]  H. Drexler,et al.  Widespread intraspecies cross‐contamination of human tumor cell lines arising at source , 1999, International journal of cancer.

[17]  E. Radany,et al.  erbB-2 overexpression in human mammary epithelial cells confers growth factor independence. , 1999, Endocrinology.

[18]  J. A. Taylor,et al.  Development and population study of an eight-locus short tandem repeat (STR) multiplex system. , 1998, Journal of forensic sciences.

[19]  D. Larsimont,et al.  Establishment and characterization of three new breast‐cancer cell lines , 1998, International journal of cancer.

[20]  C. Brown.  Role of the X chromosome in cancer. , 1996, Journal of the National Cancer Institute.

[21]  W. J. Brammar,et al.  Loss of heterozygosity on the X chromosome in human breast cancer , 1995, Genes, chromosomes & cancer.

[22]  J. Russo,et al.  Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. , 1990, Cancer research.

[23]  P. Kahn,et al.  Cellular tumorigenicity in nude mice. Test of associations among loss of cell-surface fibronectin, anchorage independence, and tumor-forming ability , 1979, The Journal of cell biology.

[24]  J. Ortaldo,et al.  Role of interferon in augmentation of natural and antibody-dependent cell-mediated cytotoxicity. , 1978, Cancer treatment reports.

[25]  S. L. Dixon,et al.  Introduction: Basic Principles , 2014 .

[26]  M. Ouellette,et al.  Use of exogenous hTERT to immortalize primary human cells , 2004, Cytotechnology.

[27]  J. Feunteun.  [A paradox and three egnimas about the role of BRCA1 in breast and ovarian cancers]. , 2004, Journal de la Société de Biologie.

[28]  J. Feunteun.  Un paradoxe et trois énigmes à propos du rôle de BRCA1 dans les cancers du sein et de l’ovaire , 2004 .

[29]  Route de Narbonne.  Risky immortalization by telomerase , 2000 .

[30]  R. Freshney.  Animal cell culture : a practical approach , 1992 .

[31]  Meijia Gu,et al.  Cancer Cell International Establishment and Characterization of Three New Human Breast Cancer Cell Lines Derived from Chinese Breast Cancer Tissues , 2022 .